Skip to content

Clinical trials

Phase 2 Hepatitis C trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Country / region: United States Clear all

155 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20024
20033
20044
20058
20068
20079
20087
200912
201024
201115
201211
20139
20149
20158
20163
20175
20184
20193
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed130
Terminated14
Unknown status7
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences37
Bristol-Myers Squibb13
National Institute of Allergy and Infectious Diseases (NIAID)12
AbbVie (prior sponsor, Abbott)7
Vertex Pharmaceuticals Incorporated6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Conatus Pharmaceuticals Inc.4
Debiopharm International SA4
Pfizer3
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C155
Hepatitis C, Chronic30
Hepatitis17
HIV Infections11
Liver Diseases10
Fibrosis9
Liver Cirrhosis5
Carcinoma, Hepatocellular4
Infections4
Bronchiolitis Obliterans Syndrome3

Trials

Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.

55 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.